GenChem & GenPharm (Changzhou) Co.,Ltd.

GenChem & GenPharm (Changzhou) Co.,Ltd., formerly Genchem (Changzhou) Co., Ltd., located in 658 Yulong Road N., Binjiang Industrial park, Xinbei, Changzhou, Jiangsu Province. At present, we have formed a unique product chain from R&D, production to sales, including alkali metal alkoxide, amino acid protecting reagent, protected amino acid and other anti-cancer, antiviral drug intermediates, as well as key intermediates of polypeptide compounds in the forefront of biopharmaceuticals in the world.

The R&D center of GenChem & GenPharm (Changzhou) Co., Ltd. is located in Changzhou. It is a high-tech enterprise, an enterprise technology center, a research center of pharmaceutical engineering technology for polypeptide and its derivatives and an excellent postgraduate workstation in Jiangsu Province. The R&D center has strong R&D and innovation capabilities in process development, process optimization and analytical method development. The technological innovation and industrialization of granular alkali metal alkoxide series products independently developed by the company won the second prize for scientific and technological progress of Sinopec Federation, and the third prize for scientific and technological progress of Sinopec Federation for key technologies of R&D and industrialization for cleaner production of amino acid protecting reagent.

GenChem & GenPharm (Changzhou) Co., Ltd. is a Sino-foreign joint venture driven by technological innovation and serving the global pharmaceutical market. The company has established a sound quality system, won the Changzhou Mayor's Quality Award and was awarded an advanced quality management unit, We have compiled the national industry standards for five products. We are a credit AAA-level enterprise of Jiangsu industrial enterprises, and "amino acid protecting reagent" is recognized as a famous brand product of Jiangsu Province. The company's main products occupy nearly 50% of the domestic and international market, and gradually grow into "industry giant", and will extend to the high-end industry chain of APIs and formulations of antiviral, anticancer drugs and polypeptide drugs.

PLANT AREA

QUALIFICATIONS AND AWARDS